Virtus Lifesci Biotech Etf Total Asset
| BBC Etf | USD 26.85 0.73 2.79% |
Virtus LifeSci Biotech fundamentals help investors to digest information that contributes to Virtus LifeSci's financial success or failures. It also enables traders to predict the movement of Virtus Etf. The fundamental analysis module provides a way to measure Virtus LifeSci's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Virtus LifeSci etf.
Virtus |
Virtus LifeSci Biotech ETF Total Asset Analysis
Virtus LifeSci's Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Current Virtus LifeSci Total Asset | 18.12 M |
Most of Virtus LifeSci's fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Virtus LifeSci Biotech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
| Competition |
Based on the latest financial disclosure, Virtus LifeSci Biotech has a Total Asset of 18.12 M. This is much higher than that of the Virtus family and significantly higher than that of the Health category. The total asset for all United States etfs is notably lower than that of the firm.
Virtus Total Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Virtus LifeSci's direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the etfs which would be a good addition to a portfolio. Peer analysis of Virtus LifeSci could also be used in its relative valuation, which is a method of valuing Virtus LifeSci by comparing valuation metrics of similar companies.Virtus LifeSci is currently under evaluation in total asset as compared to similar ETFs.
Fund Asset Allocation for Virtus LifeSci
The fund consists of 98.9% investments in stocks, with the rest of investments allocated between various types of exotic instruments.Asset allocation divides Virtus LifeSci's investment portfolio among different asset categories to balance risk and reward by investing in a diversified mix of instruments that align with the investor's goals, risk tolerance, and time horizon. Mutual funds, which pool money from multiple investors to buy a diversified portfolio of securities, use asset allocation strategies to manage the risk and return of their portfolios.
Mutual funds allocate their assets by investing in a diversified portfolio of securities, such as stocks, bonds, cryptocurrencies and cash. The specific mix of these securities is determined by the fund's investment objective and strategy. For example, a stock mutual fund may invest primarily in equities, while a bond mutual fund may invest mainly in fixed-income securities. The fund's manager, responsible for making investment decisions, will buy and sell securities in the fund's portfolio as market conditions and the fund's objectives change.
Virtus Fundamentals
| Price To Earning | 39.87 X | |||
| Price To Book | 1.75 X | |||
| Price To Sales | 1.99 X | |||
| Number Of Employees | 347 | |||
| Beta | 0.99 | |||
| Total Asset | 18.12 M | |||
| One Year Return | 42.50 % | |||
| Three Year Return | (13.60) % | |||
| Five Year Return | (1.70) % | |||
| Net Asset | 18.12 M | |||
| Equity Positions Weight | 98.90 % |
About Virtus LifeSci Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Virtus LifeSci Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Virtus LifeSci using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Virtus LifeSci Biotech based on its fundamental data. In general, a quantitative approach, as applied to this etf, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Virtus LifeSci Biotech is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Virtus Etf is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Virtus Lifesci Biotech Etf. Highlighted below are key reports to facilitate an investment decision about Virtus Lifesci Biotech Etf:Check out Virtus LifeSci Piotroski F Score and Virtus LifeSci Altman Z Score analysis. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
The market value of Virtus LifeSci Biotech is measured differently than its book value, which is the value of Virtus that is recorded on the company's balance sheet. Investors also form their own opinion of Virtus LifeSci's value that differs from its market value or its book value, called intrinsic value, which is Virtus LifeSci's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Virtus LifeSci's market value can be influenced by many factors that don't directly affect Virtus LifeSci's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Virtus LifeSci's value and its price as these two are different measures arrived at by different means. Investors typically determine if Virtus LifeSci is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Virtus LifeSci's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.